Impact of rheumatoid arthritis, seropositivity and disease-modifying anti-rheumatic drugs on mortality risk in bronchiectasis
Background: Comorbid rheumatoid arthritis (RA) is known to be associated with excess mortality in patients with bronchiectasis. However, whether excess mortality is affected by RA seropositivity and is altered by using disease-modifying anti-rheumatic drugs (DMARDs) remains unknown. Objectives: To a...
Saved in:
| Main Authors: | Hayoung Choi, Kyungdo Han, Jin Hyung Jung, Anthony De Soyza, Hyungjin Kim, Dong Wook Shin, Hyun Lee |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2025-08-01
|
| Series: | Therapeutic Advances in Respiratory Disease |
| Online Access: | https://doi.org/10.1177/17534666251360071 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Association between rheumatoid arthritis and interstitial lung disease and impact of serologic status: a large-scale longitudinal study
by: Bo-Guen Kim, et al.
Published: (2025-02-01) -
Disease Severity and Activity in Bronchiectasis: A Paradigm Shift in Bronchiectasis Management
by: Yunjoo Im, et al.
Published: (2025-01-01) -
Comprehensive and advanced T cell cluster analysis for discriminating seropositive and seronegative rheumatoid arthritis
by: Shinji Maeda, et al.
Published: (2025-07-01) -
A Seropositive Nodular Rheumatoid Polyarthritis without Arthritis: Does It Exist?
by: Fatma Ben Fredj Ismail, et al.
Published: (2012-01-01) -
Blood serotonin and joint pain in seropositive versus seronegative rheumatoid arthritis
by: Sigvard Kopp, et al.
Published: (2002-01-01)